Evidence map›Paper›PMID 34127184›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2021

Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.

Andrea Kokorovic, Alan I So, Hosam Serag, Christopher French, Robert J Hamilton, Jason P Izard, Jasmir G Nayak, Fréderic Pouliot, Fred Saad, Bobby Shayegan and 2 more

Erratum issued 2 registry-linked trialsAbstract read
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05802121 early_phase1recruitingnot on this mapstarted 2025, after this paper: background citation

The Role of Akkermansia Muciniphilia in Combating the Metabolic Effects of Androgen Deprivation Therapy in Men With Metastatic Prostate Cancer

TypeinterventionalSponsorWestern UniversityRan2025 to 2027Enrolled30ConditionsProstate Cancer, Metabolic Syndrome, Obesity, Cardiovascular MorbidityArmsApple Cider Vinegar
NCT06838520 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

A Prospective Study on the Impact of Androgen Deprivation Therapy (ADT) and Androgen Receptor Pathway Inhibitors (ARPI) on Bone Loss in Prostate Cancer Patients

TypeobservationalSponsorThe First Affiliated Hospital with Nanjing Medical UniversityRan2025 to 2030Enrolled200ConditionsProstate Cancer (Adenocarcinoma)ArmsBone health assessment
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Gender bias in shared decision-making among cancer care guidelines: A systematic review.Health expectations : an international journal of public participation in health care and health policy · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Assessing the methodologic heterogeneity of Canadian Urological Association guidelines Adoption of the GRADE approach (2018-2023).Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies Summary of changes.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  13. Secondary Osteoporosis and Metabolic Bone Diseases.Journal of clinical medicine · 2022
    Review
  14. Endocrine therapies for breast and prostate cancers: Essentials for primary care.Canadian family physician Medecin de famille canadien · 2022
    Article
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Andrea KokorovicCentre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Alan I SoDepartment of Urological Sciences, University of British Columbia, Vancouver, BC, Canada.
Hosam SeragDepartment of Urological Sciences, University of British Columbia, Vancouver, BC, Canada.
Christopher FrenchDepartment of Surgery, Division of Urology, Memorial University, St. John's, NL, Canada.
Robert J HamiltonDivision of Urology, Department of Surgery, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Jason P IzardDepartment of Urology, Queen's University, Kingston, ON, Canada.
Jasmir G NayakSection of Urology, Department of Surgery, University of Manitoba, Winnipeg, MB, Canada.
Fréderic PouliotCHU de Quebec, Université Laval, Quebec City, QC, Canada.
Fred SaadCentre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Bobby ShayeganDepartment of Surgery (Urology) and Oncology, McMaster University, Hamilton, ON, Canada.
Armen AprikianMcGill University Health Centre, Montreal, QC, Canada.
Ricardo A RendonDepartment of Urology, Dalhousie, University, Halifax, NS, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34127184
PMCPMC8195588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.